Quality Control Certificate and Analytical Method Requirements in Guatemala

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Guatemalan device registration requires two quality-related documents: the quality control certificate (Article 5.1.9, issued by the manufacturing laboratory and signed and sealed by the responsible professional) and the analytical methods (Article 5.1.8, marked as submitted when applicable). The quality control certificate is a mandatory item, while the analytical methods are conditional. The relationship between the two is complementary: the certificate states the result, and the methods explain how the result was obtained. Whether the methods must be filed depends on whether the product enters the scope of LNS testing, which in turn follows from the risk class. Organising these two documents as a matched pair — result and method, drawn from the same laboratory against the same specifications — is what makes the quality argument of the dossier close cleanly in front of the reviewer.

  • The quality control certificate is issued by the manufacturing laboratory, not by the importer or the registration holder.
  • The certificate is signed and sealed by the responsible professional of that laboratory.
  • Analytical methods are filed when applicable, judged by the classification outcome.
  • Class I is exempt from testing, so analytical methods are typically not required; Classes II to IV enter LNS testing.
  • The certificate and the specifications of Article 5.1.3 must correspond item by item.
  • On the reagent side, NT-40 Article 4.1.4 requires the certificate in original form.

2. Legal basis

The table below brings together the clauses that govern the certificate and the methods on both the device side and the reagent side. Reading the two sides together clarifies where the wording differs and where the practical path converges.

DocumentClauseContent
NT 37, Versión 5-2016 (2016-02-22)Article 5.1.9Quality control certificate issued by the manufacturing laboratory, signed and sealed by the responsible professional
NT 37, Versión 5-2016Article 5.1.8Analytical methods (Metodología analítica), submitted when applicable
NT 37, Versión 5-2016Annex 1The risk class determines whether physicochemical and microbiological testing is required
NT 37, Versión 5-2016Article 11.3The registration may be revoked where the product fails to comply with the quality control established in the manufacturer’s specifications
NT 40, Versión 3-2015Article 4.1.4Reagent side: original product quality control certificate issued by the manufacturing laboratory

3. Expert insights

Insight one: the issuing party of the quality control certificate is the manufacturing laboratory, not the importer or the registration holder. Article 5.1.9 reads “emitido por el laboratorio fabricante”, and the signatory is the responsible professional of that laboratory. This makes the certificate a direct evidentiary chain between the manufacturing side in the country of origin and the registration side in Guatemala, and it is a document the registration holder cannot produce on its own. Any attempt to substitute an internally generated test record for the laboratory certificate breaks that chain, and the defect is visible on the face of the document because the signatory and the issuing entity will not match the clause.

Insight two: the quality control certificate and the specifications file form a closed loop. Article 5.1.3 supplies the finished product specifications, and Article 5.1.9 supplies the results of testing performed against those specifications. A mismatch between the two documents is the gap most easily caught at review. Moreover, Article 11.3 lists non-compliance with the quality control established in the manufacturer’s specifications as a ground for revocation, which shows that the loop remains under examination after the product reaches the market. The certificate is therefore not a filing formality but a standing commitment whose terms can be tested at any later point.

Insight three: the conditionality of the analytical methods is tied to the testing obligation. Article 5.1.8 carries “cuando aplique”. Class I is exempt from testing under Annex 1, so analytical methods are typically not required; Classes II to IV enter LNS testing, where the methods are the basis on which the testing is carried out, so the likelihood of submission is high. The determining factor is the classification outcome, not the technical complexity of the product — a simple sterile device is squarely in scope while a sophisticated non-sterile external-use device may not be. Judging the obligation from the class avoids both omissions and unnecessary filings.

Insight four: the reagent side demands an original, in its wording. NT-40 Article 4.1.4 reads “Certificado original de control de calidad”, in contrast with the device side of Article 5.1.9, which does not emphasise the original. Under Article 4.2.1, however, the original may likewise be replaced by a notarially authenticated photocopy. The difference between the two sides is thus one of expression, and the practical operating path is close to identical: obtain the laboratory original, keep it available, and prepare an authenticated copy where substitution is needed.

4. Practical recommendations

  • Have the quality control certificate issued by the manufacturing laboratory, verify the signatory’s professional credentials, and never have the registration holder issue it itself.
  • Match the test items on the certificate against the finished product specifications of Article 5.1.3 item by item, and do not issue the certificate where inconsistencies remain.
  • Judge the submission of analytical methods from the classification outcome: prepare an explanatory note for Class I and file formally for Classes II to IV.
  • On the reagent side, prepare the original under Article 4.1.4 or a notarially authenticated photocopy.
  • Bring the certificate and the methods under change management, updating them in step with any process or specification change.

5. Verification checklist

  • □ The quality control certificate is issued by the manufacturing laboratory
  • □ The signatory is the responsible professional of that laboratory and the seal is affixed
  • □ The certificate’s test items correspond item by item with the finished product specifications
  • □ Applicability of the analytical methods has been judged from the classification outcome
  • □ On the reagent side, the original or a notarially authenticated photocopy has been prepared under Article 4.1.4
  • □ The certificate and the methods are under change management

Regulatory information verified as of October 29, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail